InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Holles Natalie C.. Officer active across 2 companies, notably Third Harmonic Bio, Inc.. In total, 4 filings have been logged. History available since 11 April 2024. The latest transaction was disclosed on 9 May 2024 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Holles Natalie C. is CEO at Third Harmonic Bio, Inc. and director at Day One Biopharmaceuticals, Inc. She has 4 filings in total, and the recent filings tracked cover the period from 2024-04-15 to 2026-04-23. The modal transaction type is Levée d'options, and the visible amounts in these recent filings include EUR 78749.32673985799 and EUR 53085.10280055145.